{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T20:12:30Z","timestamp":1696795950954},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[1999,1,29]],"date-time":"1999-01-29T00:00:00Z","timestamp":917568000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1038\/sj.bjc.6690128","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:02:07Z","timestamp":1032271327000},"page":"802-806","source":"Crossref","is-referenced-by-count":3,"title":["Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)"],"prefix":"10.1038","volume":"79","author":[{"given":"A","family":"Kuin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A van der","family":"Valk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L A","family":"Smets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,1,29]]},"reference":[{"key":"BF6690128_CR1","first-page":"308","volume":"28","author":"CA Hoefnagel","year":"1987","unstructured":"Hoefnagel, C. A., Vo\u00fbte, P. A., de Kraker, J. & Marcuse, H. R. (1987a). Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine. J Nucl Med 28: 308\u2013314.","journal-title":"J Nucl Med"},{"key":"BF6690128_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF00256489","volume":"13","author":"CA Hoefnagel","year":"1987","unstructured":"Hoefnagel, C. A., den Hartog Jager, F. C. A., Taal, B. G., Abeling, NGGM & Engelsman, E. E. (1987b). The role of I-131-MIBG in the diagnosis and therapy of carcinoids. Eur J Nucl Med 13: 187\u2013191.","journal-title":"Eur J Nucl Med"},{"key":"BF6690128_CR3","unstructured":"Hoefnagel, C. A., Taal, B. G., Sivro, F., Boot, H. & Vald\u00e9s Olmos, R. A. (1998). Enhancement of I-131 MIBG uptake in carcinoid tumors by administration of unlabelled MIBG. Hybridoma, (in press)"},{"key":"BF6690128_CR4","first-page":"3920","volume":"47","author":"S Jaques","year":"1987","unstructured":"Jaques, S., Tobes, M. C. & Sisson, J. C. (1987). Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one. Cancer Res 47: 3920\u20133928.","journal-title":"Cancer Res"},{"key":"BF6690128_CR5","first-page":"3785","volume":"54","author":"A Kuin","year":"1994","unstructured":"Kuin, A., Smets, L. A., Volk, T., Paans, A., Adams, G., Atema, A., J\u00e4hde, E., Maas, A., Rajewsky, M. F., Visser, G. & Wood, P. (1994). Reduction of intratumoral pH by the mitochondrial inhibitor m-iodobenzylguanidine and moderate hyperglycemia. Cancer Res 54: 3785\u20133792.","journal-title":"Cancer Res"},{"key":"BF6690128_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s002800050782","volume":"42","author":"A Kuin","year":"1998","unstructured":"Kuin, A., Aalders, M., van der Valk, M. A., Frey, A., Schmidt, HHHW & Smets, L. A. (1998). Renal toxicity of the neuron-blocking and mitochondriotropic agent m-iodobenzylguanidine (MIBG). Cancer Chemother Pharmacol 42: 37\u201345.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6690128_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ijc.2910460223","volume":"46","author":"C Loesberg","year":"1990","unstructured":"Loesberg, C., van Rooij, H., Nooijen, W. J., Meijer, A. J. & Smets, L. A. (1990a). Impaired mitochondrial respiration and stimulated glycolysis by m-iodobenzylguanidine (MIBG). Int J Cancer 46: 276\u2013281.","journal-title":"Int J Cancer"},{"key":"BF6690128_CR8","first-page":"92","volume":"1037","author":"C Loesberg","year":"1990","unstructured":"Loesberg, C., van Rooij, H. & Smets, L. A. (1990b). Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation). Biochem Biophys Acta 1037: 92\u201399.","journal-title":"Biochem Biophys Acta"},{"key":"BF6690128_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ijc.2910540221","volume":"54","author":"M Rutgers","year":"1993","unstructured":"Rutgers, M., Tytgat, G. A. M., Verwijs-Janssen, M., Buitenhuis, C., Vo\u00fbte, P. A. & Smets, L. A. (1993). Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells. Int J Cancer 54: 290\u2013295.","journal-title":"Int J Cancer"},{"key":"BF6690128_CR10","first-page":"96","volume":"1","author":"JC Sisson","year":"1986","unstructured":"Sisson, J. C. & Wieland, D. M. (1986). Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am J Physiol Imaging 1: 96\u2013103.","journal-title":"Am J Physiol Imaging"},{"key":"BF6690128_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00262730","volume":"21","author":"LA Smets","year":"1988","unstructured":"Smets, L. A., Bout, B. & Wisse, J. (1988). Cytotoxic and antitumor effects of the norepinephrine analogue meta-iodo-benzylguanidine (MIBG). Cancer Chemother Pharmacol 21: 9\u201313.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6690128_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ijc.2910480421","volume":"48","author":"LA Smets","year":"1991","unstructured":"Smets, L. A., Janssen, M., Rutgers, M., Ritzen, K. & Buitenhuis, C. (1991). Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells. Int J Cancer 48: 609\u2013615.","journal-title":"Int J Cancer"},{"key":"BF6690128_CR13","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.94.5.2031","volume":"94","author":"A Sparreboom","year":"1997","unstructured":"Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H. & van Tellingen, O. (1997). Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 94: 2031\u20132035.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690128_CR14","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1200\/JCO.1996.14.6.1829","volume":"14","author":"BG Taal","year":"1996","unstructured":"Taal, B. G., Hoefnagel, C. A., Valdes Olmos, R. A., Boot, H. & Beijnen, J. H. (1996a). Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors. J Clin Oncol 14: 1829\u20131838.","journal-title":"J Clin Oncol"},{"key":"BF6690128_CR15","first-page":"A36","volume":"8","author":"BG Taal","year":"1996","unstructured":"Taal, B. G., Hoefnagel, C. A., Valdes Olmos, R. A. & Boot, J. H. (1996b). The effect of unlabelled MIBG prior to 131I-MIBG scanning and its potential benefit in the treatment of metastatic carcinoid. Eur J Gastroent Hep 8: A36(abstract)","journal-title":"Eur J Gastroent Hep"},{"key":"BF6690128_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/BF00173043","volume":"21","author":"AR Wafelman","year":"1994","unstructured":"Wafelman, A. R., Hoefnagel, C. A., Maes, R. A. A. & Beijnen, J. H. (1994). Radioiodinated meta-iodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med 21: 545\u2013559.","journal-title":"Eur J Nucl Med"},{"key":"BF6690128_CR17","first-page":"349","volume":"21","author":"DM Wieland","year":"1980","unstructured":"Wieland, D. M., Wu, J. I., Brown, L. E., Mangner, T. J., Swanson, D. P. & Beierwaltes, W. H. (1980). Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 21: 349\u2013353.","journal-title":"J Nucl Med"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690128","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:50:36Z","timestamp":1684414236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1,29]]},"references-count":17,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["BF6690128"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690128","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1,29]]}}}